Historical record - last NADAC effective date: 1/18/2023
Product Information
DEXTROAMPHETAMINE ER 5 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.8684 per EA under NDC 00115992710. Its NADAC has been published 206 times since Mar 20, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115992710
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
1/18/2023
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017078FDA Approved
Before 1982
TE Code
AB
On Market Since
8/2/1976
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has been published 206 times since Mar 20, 2019, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8684 per EA |
|---|---|
| All-time high | $1.6289 (Dec 11, 2019) |
| All-time low | $0.8223 (Aug 17, 2022) |
| Median price | $1.1690 |
| Average price | $1.1572 |
| Largest weekly change | +57.3% (Mar 18, 2020) |
| Weeks tracked | 206 |
| Tracking since | Mar 20, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-27.0%
All
-34.2%
Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE ER 5 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.8684 per EA (NDC 00115992710), effective Feb 22, 2023.
How has the price of DEXTROAMPHETAMINE ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has declined 34.2%. It has been tracked across 206 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE ER 5 MG CAP?
Since Mar 20, 2019, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has ranged from a low of $0.8223 (Aug 17, 2022) to a high of $1.6289 (Dec 11, 2019), with a median of $1.1690 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE ER 5 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPHETAMINE ER 5 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPHETAMINE ER 5 MG CAP?
DEXTROAMPHETAMINE ER 5 MG CAP (NDC 00115992710) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.